Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

OBJECTIVE: Fas/Fas ligand (FasL) and B cell-activating factor (BAFF) signalling have pivotal roles in SLE pathogenesis. We investigated the clinical associations of serum concentrations of soluble Fas (sFas) and soluble FasL (sFasL) in SLE and their relationship with BAFF. METHODS: Serum sFas and sF...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lupus Sci Med
Autors principals: Vincent, Fabien B, Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Harris, James, Hoi, Alberta Y, Mackay, Fabienne, Morand, Eric F
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Biomarker Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299016/
https://ncbi.nlm.nih.gov/pubmed/32546562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2019-000375
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars